AUA: Upper Tract Urothelial Carcinoma (2023): Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 121: | Line 121: | ||
***# '''<span style="color:#ff0000">Appearance (sessile, papillary, flat/villous)''' | ***# '''<span style="color:#ff0000">Appearance (sessile, papillary, flat/villous)''' | ||
***# '''<span style="color:#ff0000">Quality of visualization </span>''' | ***# '''<span style="color:#ff0000">Quality of visualization </span>''' | ||
***# | ***#*Can impact the accuracy of endoscopic inspection (e.g., bleeding, difficulty in access, tumor location, artifacts from instrumentation) and should be documented in endoscopic reports. | ||
*** See checklist in [https://www.auanet.org/guidelines-and-quality/guidelines/non-metastatic-upper-tract-urothelial-carcinoma Guidelines Statement 2,Table 3: Standardized Upper Tract Endoscopy Suggested Reporting Elements] | *** See checklist in [https://www.auanet.org/guidelines-and-quality/guidelines/non-metastatic-upper-tract-urothelial-carcinoma Guidelines Statement 2,Table 3: Standardized Upper Tract Endoscopy Suggested Reporting Elements] | ||
** '''<span style="color:#ff0000">Biopsy of any identified lesion</span>''' | ** '''<span style="color:#ff0000">Biopsy of any identified lesion</span>''' | ||